News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Federal Trade Commission OKs Novartis AG (NVS)' $1.5 Billion Fougera (AAA) Buy With Divestitures


7/17/2012 7:29:48 AM

Antitrust regulators told Swiss drugmaker Novartis AG it will have to give up marketing rights to four skin care products as part of its $1.53 billion deal for dermatology drug maker Fougera Pharmaceuticals. The Federal Trade Commission told Novartis it needs to sell three drugs and return the rights to a fourth product to its manufacturer. The FTC is requiring Novartis to sell the products, which include a topical anesthetic and a treatment for psoriasis, because Novartis and Fougera both have large shares of the U.S. market for the products.

Read at News Release
Read at BusinessWeek
Read at Reuters


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES